89bio, Inc.
ETNB
NASDAQ
Headlines
There are no news to display.
Filings
Friday, March 1, 2024
Sunday, December 31, 2023
Week of May 6 and 10 (est)
Price History
--
Corporate Info
415 432 9270
142 Sansome Street
San Francisco, CA 94104
San Francisco, CA 94104
Business Description
89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product...
more